521 related articles for article (PubMed ID: 31077760)
21. NS2B-NS3 protease inhibitors as promising compounds in the development of antivirals against Zika virus: A systematic review.
Nunes DAF; Santos FRDS; da Fonseca STD; de Lima WG; Nizer WSDC; Ferreira JMS; de Magalhães JC
J Med Virol; 2022 Feb; 94(2):442-453. PubMed ID: 34636434
[TBL] [Abstract][Full Text] [Related]
22. Identification of novel and potential inhibitors against the dengue virus NS2B/NS3 protease using virtual screening and biomolecular simulations.
Nasir A; Samad A; Ajmal A; Li P; Islam M; Ullah S; Shah M; Bai Q
Int J Biol Macromol; 2024 Jun; 272(Pt 1):132855. PubMed ID: 38834129
[TBL] [Abstract][Full Text] [Related]
23. A Non-Active-Site Inhibitor with Selectivity for Zika Virus NS2B-NS3 Protease.
Cruz KG; Hill Eron M; Makhaik S; Savinov S; Hardy JA
ACS Infect Dis; 2024 Feb; 10(2):412-425. PubMed ID: 38265226
[TBL] [Abstract][Full Text] [Related]
24. Construction of dengue virus protease expression plasmid and in vitro protease assay for screening antiviral inhibitors.
Lai H; Teramoto T; Padmanabhan R
Methods Mol Biol; 2014; 1138():345-60. PubMed ID: 24696347
[TBL] [Abstract][Full Text] [Related]
25. Design and docking studies of peptide inhibitors as potential antiviral drugs for dengue virus ns2b/ns3 protease.
Velmurugan D; Mythily U; Rao K
Protein Pept Lett; 2014; 21(8):815-27. PubMed ID: 23855663
[TBL] [Abstract][Full Text] [Related]
26. Computational insight into dengue virus NS2B-NS3 protease inhibition: A combined ligand- and structure-based approach.
Chen J; Jiang H; Li F; Hu B; Wang Y; Wang M; Wang J; Cheng M
Comput Biol Chem; 2018 Dec; 77():261-271. PubMed ID: 30393100
[TBL] [Abstract][Full Text] [Related]
27. Inhibitors of the Zika virus protease NS2B-NS3.
Voss S; Nitsche C
Bioorg Med Chem Lett; 2020 Mar; 30(5):126965. PubMed ID: 31980339
[TBL] [Abstract][Full Text] [Related]
28. Identification and structural characterization of small molecule fragments targeting Zika virus NS2B-NS3 protease.
Quek JP; Liu S; Zhang Z; Li Y; Ng EY; Loh YR; Hung AW; Luo D; Kang C
Antiviral Res; 2020 Mar; 175():104707. PubMed ID: 31953156
[TBL] [Abstract][Full Text] [Related]
29. Dynamic Interactions of Post Cleaved NS2B Cofactor and NS3 Protease Identified by Integrative Structural Approaches.
Quek JP; Ser Z; Chew BLA; Li X; Wang L; Sobota RM; Luo D; Phoo WW
Viruses; 2022 Jun; 14(7):. PubMed ID: 35891424
[TBL] [Abstract][Full Text] [Related]
30. Identification of novel small molecule inhibitors against NS2B/NS3 serine protease from Zika virus.
Lee H; Ren J; Nocadello S; Rice AJ; Ojeda I; Light S; Minasov G; Vargas J; Nagarathnam D; Anderson WF; Johnson ME
Antiviral Res; 2017 Mar; 139():49-58. PubMed ID: 28034741
[TBL] [Abstract][Full Text] [Related]
31. Structure-Based Macrocyclization of Substrate Analogue NS2B-NS3 Protease Inhibitors of Zika, West Nile and Dengue viruses.
Braun NJ; Quek JP; Huber S; Kouretova J; Rogge D; Lang-Henkel H; Cheong EZK; Chew BLA; Heine A; Luo D; Steinmetzer T
ChemMedChem; 2020 Aug; 15(15):1439-1452. PubMed ID: 32501637
[TBL] [Abstract][Full Text] [Related]
32. Zika virus NS2B/NS3 proteinase: A new target for an old drug - Suramin a lead compound for NS2B/NS3 proteinase inhibition.
Coronado MA; Eberle RJ; Bleffert N; Feuerstein S; Olivier DS; de Moraes FR; Willbold D; Arni RK
Antiviral Res; 2018 Dec; 160():118-125. PubMed ID: 30393012
[TBL] [Abstract][Full Text] [Related]
33. Allosteric pocket of the dengue virus (serotype 2) NS2B/NS3 protease: In silico ligand screening and molecular dynamics studies of inhibition.
Mukhametov A; Newhouse EI; Aziz NA; Saito JA; Alam M
J Mol Graph Model; 2014 Jul; 52():103-13. PubMed ID: 25023665
[TBL] [Abstract][Full Text] [Related]
34. The Structure of the Zika Virus Protease, NS2B/NS3
Hilgenfeld R; Lei J; Zhang L
Adv Exp Med Biol; 2018; 1062():131-145. PubMed ID: 29845530
[TBL] [Abstract][Full Text] [Related]
35. Synthesis, Structure-Activity Relationships, and Antiviral Activity of Allosteric Inhibitors of Flavivirus NS2B-NS3 Protease.
Nie S; Yao Y; Wu F; Wu X; Zhao J; Hua Y; Wu J; Huo T; Lin YL; Kneubehl AR; Vogt MB; Ferreon J; Rico-Hesse R; Song Y
J Med Chem; 2021 Mar; 64(5):2777-2800. PubMed ID: 33596380
[TBL] [Abstract][Full Text] [Related]
36. Arylcyanoacrylamides as inhibitors of the Dengue and West Nile virus proteases.
Nitsche C; Steuer C; Klein CD
Bioorg Med Chem; 2011 Dec; 19(24):7318-37. PubMed ID: 22094280
[TBL] [Abstract][Full Text] [Related]
37. Solution conformations of a linked construct of the Zika virus NS2B-NS3 protease.
Mahawaththa MC; Pearce BJG; Szabo M; Graham B; Klein CD; Nitsche C; Otting G
Antiviral Res; 2017 Jun; 142():141-147. PubMed ID: 28336347
[TBL] [Abstract][Full Text] [Related]
38. SAR of novel benzothiazoles targeting an allosteric pocket of DENV and ZIKV NS2B/NS3 proteases.
Maus H; Barthels F; Hammerschmidt SJ; Kopp K; Millies B; Gellert A; Ruggieri A; Schirmeister T
Bioorg Med Chem; 2021 Oct; 47():116392. PubMed ID: 34509861
[TBL] [Abstract][Full Text] [Related]
39. Allostery in the dengue virus NS3 helicase: Insights into the NTPase cycle from molecular simulations.
Davidson RB; Hendrix J; Geiss BJ; McCullagh M
PLoS Comput Biol; 2018 Apr; 14(4):e1006103. PubMed ID: 29659571
[TBL] [Abstract][Full Text] [Related]
40. Identification of novel Zika virus NS3 protease inhibitors with different inhibition modes by integrative experimental and computational approaches.
Andrade MA; Mottin M; Sousa BKP; Barbosa JARG; Dos Santos Azevedo C; Lasse Silva C; Gonçalves de Andrade M; Motta FN; Maulay-Bailly C; Amand S; Santana JM; Horta Andrade C; Grellier P; Bastos IMD
Biochimie; 2023 Sep; 212():143-152. PubMed ID: 37088408
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
